retatrutide legal status Promises Big Weight Loss, but Safety Remains a Question Retatrutide is a new GLP-1

Several other indications are under study, including obstructive sleep apnea, MASLD, knee osteoarthritis, chronic kidney disease, and cardiovascular outcomes

Researchers also suspect that some amino acids (the building blocks of protein) more efficiently increase GLP-1 than others, as demonstrated in one animal model

At PRIME Medicine we take every precaution possible to ensure that side effects are as limited as possible

GLP-1 agonists have been shown to reduce binge-eating episodes, abnormal eating patterns, weight, and BMI (though BMI is a very flawed metric!)

Medicare and Medicaid coverage also varies by plan formulary and the reason for taking the medication

You need both measurements to know what's happening